- Home
- NEO vs IRS Comparison
NEO vs IRS Comparison
Compare NEO & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- IRS
- Stock Information
- Founded
- NEO 2001
- IRS 1943
- Country
- NEO United States
- IRS Argentina
- Employees
- NEO N/A
- IRS N/A
- Industry
- NEO Precision Instruments
- IRS Homebuilding
- Sector
- NEO Health Care
- IRS Real Estate
- Exchange
- NEO Nasdaq
- IRS Nasdaq
- Market Cap
- NEO 965.2M
- IRS 1.1B
- IPO Year
- NEO 1999
- IRS 1994
- Fundamental
- Price
- NEO $7.00
- IRS $13.89
- Analyst Decision
- NEO Buy
- IRS Strong Buy
- Analyst Count
- NEO 9
- IRS 1
- Target Price
- NEO $13.31
- IRS $12.62
- AVG Volume (30 Days)
- NEO 2.0M
- IRS 144.5K
- Earning Date
- NEO 07-28-2025
- IRS 05-06-2025
- Dividend Yield
- NEO N/A
- IRS 11.66%
- EPS Growth
- NEO N/A
- IRS N/A
- EPS
- NEO N/A
- IRS 0.20
- Revenue
- NEO $672,361,000.00
- IRS $308,539,877.00
- Revenue This Year
- NEO $13.97
- IRS N/A
- Revenue Next Year
- NEO $11.36
- IRS N/A
- P/E Ratio
- NEO N/A
- IRS $6.33
- Revenue Growth
- NEO 10.10
- IRS N/A
- 52 Week Low
- NEO $6.08
- IRS $7.93
- 52 Week High
- NEO $19.12
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- NEO 40.74
- IRS 41.77
- Support Level
- NEO $6.90
- IRS $13.40
- Resistance Level
- NEO $7.42
- IRS $14.62
- Average True Range (ATR)
- NEO 0.39
- IRS 0.68
- MACD
- NEO -0.00
- IRS -0.17
- Stochastic Oscillator
- NEO 13.01
- IRS 23.33
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.